These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 27125084)
1. CONCENTRATIONS OF VITREAL CYTOKINES IN RHEGMATOGENOUS RETINAL DETACHMENT. Danielescu C; Zugun-Eloae F; Zlei M Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):124-9. PubMed ID: 27125084 [TBL] [Abstract][Full Text] [Related]
2. The role of thrombin in proliferative vitreoretinopathy. Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355 [TBL] [Abstract][Full Text] [Related]
3. Immunological biomarkers of the vitreous responsible for proliferative alteration in the different forms of retinal detachment. Balogh A; Milibák T; Szabó V; Nagy ZZ; Kaarniranta K; Resch MD BMC Ophthalmol; 2020 Dec; 20(1):491. PubMed ID: 33371882 [TBL] [Abstract][Full Text] [Related]
4. Position of macula lutea and presence of proliferative vitreoretinopathy affect vitreous cytokine expression in rhegmatogenous retinal detachment. Balogh A; Milibák T; Szabó V; Nagy ZZ; Resch MD PLoS One; 2020; 15(6):e0234525. PubMed ID: 32542038 [TBL] [Abstract][Full Text] [Related]
5. Intercellular adhesion molecule-1 in proliferative vitreoretinopathy. Limb GA; Chignell AH; Cole CJ; Green WT; Webster L; Hollifield RD; Dumonde DC Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1043-8. PubMed ID: 9113001 [TBL] [Abstract][Full Text] [Related]
6. Extent of Detached Retina and Lens Status Influence Intravitreal Protein Expression in Rhegmatogenous Retinal Detachment. Pollreisz A; Sacu S; Eibenberger K; Funk M; Kivaranovic D; Zlabinger GJ; Georgopoulos M; Schmidt-Erfurth U Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5493-502. PubMed ID: 26284555 [TBL] [Abstract][Full Text] [Related]
8. C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy. Capeans C; De Rojas MV; Lojo S; Salorio MS Retina; 1998; 18(6):546-50. PubMed ID: 9869464 [TBL] [Abstract][Full Text] [Related]
9. Elevated erythropoietin in vitreous of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy. Wang ZY; Shen LJ; Zhao KK; Song ZM; Qu J Ophthalmic Res; 2009; 42(3):138-40. PubMed ID: 19602911 [TBL] [Abstract][Full Text] [Related]
10. Analysis of the molecular biologic milieu of the vitreous in proliferative vitreoretinopathy. Wladis EJ; Falk NS; Iglesias BV; Beer PM; Gosselin EJ Retina; 2013 Apr; 33(4):807-11. PubMed ID: 23222459 [TBL] [Abstract][Full Text] [Related]
11. Vitreous levels of Lipocalin-2 on patients with primary rhegmatogenous retinal detachment. Batsos G; Christodoulou E; Vartholomatos G; Galanis P; Stefaniotou M PLoS One; 2019; 14(12):e0227266. PubMed ID: 31891637 [TBL] [Abstract][Full Text] [Related]
13. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy. Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136 [TBL] [Abstract][Full Text] [Related]
14. Altered Decorin Biology in Proliferative Vitreoretinopathy: A Mechanistic and Cohort Study. Begum G; O'Neill J; Chaudhary R; Blachford K; Snead DRJ; Berry M; Scott RAH; Logan A; Blanch RJ Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):4929-4936. PubMed ID: 30347087 [TBL] [Abstract][Full Text] [Related]
15. Postoperative proliferative vitreoretinopathy development is linked to vitreal CXCL5 concentrations. Zandi S; Pfister IB; Garweg JG Sci Rep; 2021 Dec; 11(1):23989. PubMed ID: 34907233 [TBL] [Abstract][Full Text] [Related]
16. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy. Dieudonné SC; La Heij EC; Diederen RM; Kessels AG; Liem AT; Kijlstra A; Hendrikse F Ophthalmic Res; 2007; 39(3):148-54. PubMed ID: 17534114 [TBL] [Abstract][Full Text] [Related]
17. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. Kon CH; Occleston NL; Aylward GW; Khaw PT Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):705-12. PubMed ID: 10067974 [TBL] [Abstract][Full Text] [Related]
18. Chemokine levels in subretinal fluid obtained during scleral buckling surgery after rhegmatogenous retinal detachment. Ricker LJ; Kijlstra A; de Jager W; Liem AT; Hendrikse F; La Heij EC Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4143-50. PubMed ID: 20335622 [TBL] [Abstract][Full Text] [Related]
19. Intraocular concentrations of cytokines and chemokines in rhegmatogenous retinal detachment and the effect of intravitreal triamcinolone acetonide. Kunikata H; Yasuda M; Aizawa N; Tanaka Y; Abe T; Nakazawa T Am J Ophthalmol; 2013 Jun; 155(6):1028-1037.e1. PubMed ID: 23490191 [TBL] [Abstract][Full Text] [Related]
20. Adipokine levels in subretinal fluid from patients with rhegmatogenous retinal detachment. Ricker LJ; Kijlstra A; Kessels AG; de Jager W; Hendrikse F; La Heij EC Exp Eye Res; 2012 Jan; 94(1):56-62. PubMed ID: 22138416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]